Mulmit

IOVANCE BIOTHERAPEUTICS, INC.IOVANCE BIOTHERAPEUTICS, INC.

IOVA Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31263,502,000-403,356,000-391,000,000-1.09
2024-12-31164,070,000-395,278,000-372,200,000-1.28
2023-12-311,189,000-460,559,000-444,000,000-1.89

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-01Vogt Frederick GInterim CEO & General Counsel41,669
2026-09-01Vogt Frederick GInterim CEO & General Counsel17,702
2026-09-01Vogt Frederick GInterim CEO & General Counsel41,669
2026-09-01Puri Raj K.Chief Regulatory Officer5,470
2026-09-01Puri Raj K.Chief Regulatory Officer2,508
2026-09-01Puri Raj K.Chief Regulatory Officer5,470
2026-09-01BILINSKY IGORChief Operating Officer8,789
2026-09-01BILINSKY IGORChief Operating Officer4,472
2026-09-01BILINSKY IGORChief Operating Officer8,789
2026-08-10Kirby Daniel GordonChief Commercial Officer10,001
2026-08-10Kirby Daniel GordonChief Commercial Officer2,436
2026-08-10Kirby Daniel GordonChief Commercial Officer10,001

8-K events

FiledItems
2026-08-06Other events · Financial statements and exhibits
2026-08-06Results of operations · Financial statements and exhibits
2026-07-02Other events · Financial statements and exhibits
2026-06-10Submission of matters to a vote · Other events · Financial statements and exhibits
2026-05-07Results of operations · Financial statements and exhibits
2026-03-20Officer or director change
2026-02-24Results of operations · Other events · Financial statements and exhibits
2026-01-09Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.